-- ブルームバーグは水曜日、関係者の話として、モルガン・スタンレー（MS）が第1四半期決算発表後、ウォール街の銀行としては最大規模となる100億ドルの債券発行を計画していると報じた。 同行が発行する4つの債券は償還期間が4年から11年までとなっている。最も償還期間の長い債券の利回りは、当初の協議で提示されていた約1.25%から1.02%上回る水準となる見込みだと、関係者はブルームバーグに語った。 調達資金は一般事業目的に充当される予定だという。 モルガン・スタンレーは、MTニュースワイヤーズからのコメント要請にすぐには応じなかった。 （マーケットチャッターのニュースは、世界中の市場関係者との会話に基づいています。この情報は信頼できる情報源に基づいていると考えられますが、噂や憶測が含まれる可能性があります。正確性は保証されません。）
Price: $191.71, Change: $+8.37, Percent Change: +4.57%
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.